BACKGROUND AND PURPOSE: Electrical stimulation of the vagus nerve reduces intestinal inflammation following mechanical handling, thereby shortening post-operative ileus in mice. Previous studies in a sepsis model showed that this cholinergic anti-inflammatory pathway can be activated pharmacologically by central administration of semapimod, an inhibitor of p38 mitogen-activated protein kinase. We therefore evaluated the effect of intracerebroventricular (i.c.v.) semapimod on intestinal inflammation and post-operative ileus in mice. EXPERIMENTAL APPROACH: Mice underwent a laparotomy or intestinal manipulation 1 h after i.c.v. pre-treatment with semapimod (1 µg·kg(-1) ) or saline. Drugs were administered through a cannula placed in the left lateral ventricle 1 week prior to experimentation. Twenty-four hours after surgery, gastric emptying was measured using scintigraphy, and the degree of intestinal inflammation was assessed. Finally, activation of brain regions was assessed using quantitative immunohistochemistry for c-fos. KEY RESULTS: Intestinal manipulation induced inflammation of the manipulated intestine and significantly delayed gastric emptying, 24 h after surgery in saline-treated animals. Semapimod significantly reduced this inflammation and improved gastric emptying. Vagotomy enhanced the inflammatory response induced by intestinal manipulation and abolished the anti-inflammatory effect of semapimod. Semapimod but not saline induced a significant increase in c-fos expression in the paraventricular nucleus, the nucleus of the solitary tract and the dorsal motor nucleus of the vagus nerve. CONCLUSIONS AND IMPLICATIONS: Our findings show that i.c.v. semapimod reduces manipulation-induced intestinal inflammation and prevented post-operative ileus. This anti-inflammatory effect depends on central activation of the vagus nerve.
BACKGROUND AND PURPOSE: Electrical stimulation of the vagus nerve reduces intestinal inflammation following mechanical handling, thereby shortening post-operative ileus in mice. Previous studies in a sepsis model showed that this cholinergic anti-inflammatory pathway can be activated pharmacologically by central administration of semapimod, an inhibitor of p38 mitogen-activated protein kinase. We therefore evaluated the effect of intracerebroventricular (i.c.v.) semapimod on intestinal inflammation and post-operative ileus in mice. EXPERIMENTAL APPROACH: Mice underwent a laparotomy or intestinal manipulation 1 h after i.c.v. pre-treatment with semapimod (1 µg·kg(-1) ) or saline. Drugs were administered through a cannula placed in the left lateral ventricle 1 week prior to experimentation. Twenty-four hours after surgery, gastric emptying was measured using scintigraphy, and the degree of intestinal inflammation was assessed. Finally, activation of brain regions was assessed using quantitative immunohistochemistry for c-fos. KEY RESULTS: Intestinal manipulation induced inflammation of the manipulated intestine and significantly delayed gastric emptying, 24 h after surgery in saline-treated animals. Semapimod significantly reduced this inflammation and improved gastric emptying. Vagotomy enhanced the inflammatory response induced by intestinal manipulation and abolished the anti-inflammatory effect of semapimod. Semapimod but not saline induced a significant increase in c-fos expression in the paraventricular nucleus, the nucleus of the solitary tract and the dorsal motor nucleus of the vagus nerve. CONCLUSIONS AND IMPLICATIONS: Our findings show that i.c.v. semapimod reduces manipulation-induced intestinal inflammation and prevented post-operative ileus. This anti-inflammatory effect depends on central activation of the vagus nerve.
Authors: Wouter J de Jonge; Esmerij P van der Zanden; Frans O The; Maarten F Bijlsma; David J van Westerloo; Roelof J Bennink; Hans-Rudolf Berthoud; Satoshi Uematsu; Shizuo Akira; Rene M van den Wijngaard; Guy E Boeckxstaens Journal: Nat Immunol Date: 2005-07-17 Impact factor: 25.606
Authors: Valentin A Pavlov; Mahendar Ochani; Margot Gallowitsch-Puerta; Kanta Ochani; Jared M Huston; Christopher J Czura; Yousef Al-Abed; Kevin J Tracey Journal: Proc Natl Acad Sci U S A Date: 2006-03-20 Impact factor: 11.205
Authors: Frans O The; Wouter J de Jonge; Roel J Bennink; Rene M van den Wijngaard; Guy E Boeckxstaens Journal: Br J Pharmacol Date: 2005-09 Impact factor: 8.739
Authors: Sven Wehner; Florian F Behrendt; Boris N Lyutenski; Mariola Lysson; Anthony J Bauer; Andreas Hirner; Jörg C Kalff Journal: Gut Date: 2006-06-29 Impact factor: 23.059
Authors: Sven Wehner; Nicolas T Schwarz; Ricarda Hundsdoerfer; Christian Hierholzer; David J Tweardy; Timothy R Billiar; Anthony J Bauer; Joerg C Kalff Journal: Surgery Date: 2005-04 Impact factor: 3.982
Authors: Jean Eric Ghia; Patricia Blennerhassett; Harry Kumar-Ondiveeran; Elena F Verdu; Stephen M Collins Journal: Gastroenterology Date: 2006-08-15 Impact factor: 22.682
Authors: David J van Westerloo; Ilona A Giebelen; Sandrine Florquin; Marco J Bruno; Gregory J Larosa; Luis Ulloa; Kevin J Tracey; T van der Poll Journal: Gastroenterology Date: 2006-05 Impact factor: 22.682
Authors: Frans O The; Guy E Boeckxstaens; Susanne A Snoek; Jenna L Cash; Roel Bennink; Gregory J Larosa; Rene M van den Wijngaard; David R Greaves; Wouter J de Jonge Journal: Gastroenterology Date: 2007-07-25 Impact factor: 22.682
Authors: Sjoerd H W van Bree; Andrea Nemethova; Cathy Cailotto; Pedro J Gomez-Pinilla; Gianluca Matteoli; Guy E Boeckxstaens Journal: Nat Rev Gastroenterol Hepatol Date: 2012-07-17 Impact factor: 46.802
Authors: Linyuan Wang; Darren Opland; Sue Tsai; Cynthia T Luk; Stephanie A Schroer; Margaret B Allison; Andrew J Elia; Caren Furlonger; Akira Suzuki; Christopher J Paige; Tak W Mak; Daniel A Winer; Martin G Myers; Minna Woo Journal: Nat Med Date: 2014-04-20 Impact factor: 53.440